Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis.
Sasson SC, Zaunders JJ, Nahar K, Munier CML, Fairfax BP, Olsson-Brown A, Jolly C, Read SA, Ahlenstiel G, Palendira U, Scolyer RA, Carlino MS, Payne MJ, Cheung VTF, Gupta T, Klenerman P, Long GV, Brain O, Menzies AM, Kelleher AD.
Sasson SC, et al. Among authors: scolyer ra.
Clin Exp Immunol. 2020 Dec;202(3):335-352. doi: 10.1111/cei.13502. Epub 2020 Aug 19.
Clin Exp Immunol. 2020.
PMID: 32734627
Free PMC article.
Clinical Trial.